Roche's Bid to Acquire Illumina Topped Readers' Interest in 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – Roche's bid to acquire Illumina, which was ultimately unsuccessful in the early part of 2012, topped our list of most-viewed articles on GenomeWeb Daily News for the year.

A series of articles on Roche's pursuit and Illumina's efforts to fend off the hostile takeover bid claimed six of the top 10 most-viewed articles on GWDN for 2012:

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.